Pathogenesis of systemic sclerosis: Altered B cell function is the key linking systemic autoimmunity and tissue fibrosis
Authors:
- Minoru HasegawaMHMinoru Hasegawa
- Manabu FujimotoMFManabu Fujimoto
- Kazuhiko TakeharaKTKazuhiko Takehara
- Shinichi SatoSSShinichi Sato
- 1 July 2005
- journal article
- review article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 39 (1) , 1-7
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Interleukin‐4 regulates connective tissue growth factor expression in human lung fibroblastsJournal of Cellular Biochemistry, 2002
- Effect of IL-12 Encoding Plasmid Administration on Tight-Skin MouseBiochemical and Biophysical Research Communications, 2001
- Lack of Skin Fibrosis in Tight Skin (TSK) Mice with Targeted Mutation in the Interleukin-4Rα and Transforming Growth Factor-β GenesJournal of Investigative Dermatology, 2001
- Anti-sclerotic Effect of Transforming Growth Factor-β Antibody in a Mouse Model of Bleomycin-Induced SclerodermaClinical Immunology, 1999
- Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of sclerodermaEuropean Journal of Immunology, 1998
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsJournal of Experimental Medicine, 1997
- The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and AutoimmunityImmunity, 1997
- B cells solicit their own help from T cells.Journal of Experimental Medicine, 1996
- Cytokine production and serum levels in systemic sclerosisClinical Immunology and Immunopathology, 1992
- Interleukin‐1, Interleukin‐2, Interleukin‐4, Interleukin‐6, Tumor Necrosis Factor α, and Interferon‐γ Levels in Sera from Patients With SclerodermaArthritis & Rheumatism, 1992